# Predictive Value of HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated With Antiviral Therapy

> **NCT05965388** · — · NOT_YET_RECRUITING · sponsor: **Wen-hong Zhang** · enrollment: 5000 (estimated)

## Conditions studied

- HBV
- HCC

## Interventions

- **DRUG:** nucleoside analogues or interferon

## Key facts

- **NCT ID:** NCT05965388
- **Lead sponsor:** Wen-hong Zhang
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-12-01
- **Primary completion:** 2029-02-01
- **Final completion:** 2029-02-01
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2023-07-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05965388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05965388, "Predictive Value of HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated With Antiviral Therapy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05965388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*